Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 5A pseudogene 2 (EIF5AP2) is a pseudogene and not an active protein-coding gene. Pseudogenes like EIF5AP2 are typically regarded as genomic DNA sequences similar to known genes but non-functional; they do not encode functional proteins due to disabling mutations or lack of regulatory elements required for transcription and translation. As such, EIF5AP2 does not produce a functional eukaryotic translation initiation factor 5A protein and is not involved in known cellular functions, disease roles, or therapeutic targeting. Its main relevance is in sequence similarity and potential roles in gene regulation at the RNA level, but no direct biological or therapeutic roles are attributed to this pseudogene[4]. Important context: - There is often confusion between actual protein-coding genes like EIF5A or EIF5A2 (both of which are functional and have key cellular and potential therapeutic roles)[1][2], and pseudogenes like EIF5AP2, which are non-functional copies or fragments of such genes. - EIF5AP2 is not considered a therapeutic target, does not have a defined disease linkage or known interacting drugs, and is not a source of pharmacological or biomarker interest. - If you intended to refer to the functional gene (EIF5A or EIF5A2), those have established protein products and roles in translation, cell proliferation, and cancer, but this does not apply to the EIF5AP2 pseudogene[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 5A pseudogene 2 (EIF5AP2).